Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AUTL
AUTL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AUTL News
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Globenewswire
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Newsfilter
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%
Jan 14 2026
Benzinga
Autolus Evaluates Cellares' Automated Platform for Manufacturing Expansion
Jan 06 2026
Newsfilter
Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab
Dec 29 2025
Benzinga
DigitalBridge Group Inc Acquired by SoftBank Group for Approximately $4 Billion
Dec 29 2025
Benzinga
BTIG Raises Praxis Precision Medicines Price Target to $843
Dec 29 2025
Benzinga
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg Dose
Dec 19 2025
PRnewswire
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing
Dec 19 2025
Newsfilter
Autolus Unveils New Phase I Results for Obe-cel in Challenging Lupus Cases
Dec 09 2025
NASDAQ.COM
Autolus Presents CARLYSLE Trial Preliminary Data Showing Significant B-Cell Depletion
Dec 08 2025
Globenewswire
Autolus Presents CARLYSLE Trial Preliminary Data Showing Significant B-Cell Depletion Improvement
Dec 08 2025
Newsfilter
Autolus Appoints Ryan Richardson to Board, Aiming to Expand obe-cel's Reach
Dec 01 2025
Newsfilter
Autel Signs Strategic MoU with UAEV to Enhance UAE EV Charging Network
Nov 29 2025
Businesswire
What’s Behind the Rise in Autolus Therapeutics Stock on Tuesday?
Nov 25 2025
Benzinga
Autolus Announces UK Health Authority Recommends Aucatzyl for Leukemia Treatment
Nov 25 2025
Yahoo Finance
Show More News
